SERMs (Merck Sharp & Dohme)

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSERMs (Merck Sharp & Dohme)
Drug Alias Nameestrogen receptor modulators2-phenylspiroindenesselective estrogen receptor modulators
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEstrogen receptors modulators
TargetsEstrogen receptors
Therapy Area/IndicationsOestrogen deficiency symptomsOsteoporosisBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKaro Pharma Ab
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsOestrogen deficiency symptomsOsteoporosisBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A